Dhanvantri Jeevan Rekha's Q1 financials show mixed results, with improved profitability but declining operating profit.

Dhanvantri Jeevan Rekha, a microcap healthcare services company, has recently announced its financial results for the quarter ended March 2024. According to the report, the company has seen a flat financial performance in the quarter, with a score of 2 out of 10, a decrease from the previous score of 7 in the last 3 months.

Despite this, there are some positive aspects to note from the financial results. The company's Profit After Tax (PAT) for the half-yearly period was higher at Rs 0.27 crore compared to the preceding 12-month period ended March 2024, which was at Rs -0.10 crore. This shows a significant improvement in the company's profitability, as it has already surpassed its PAT for the previous 12 months in just half a year.

However, there are also some areas of concern for Dhanvantri Jeevan Rekha. The company's Operating Profit (PBDIT) for the quarter was at its lowest in the last five quarters, at Rs 0.01 crore. This indicates a negative trend in the near term for the company's operating profit.

Based on these financial results, MarketsMOJO has given a 'Sell' call for Dhanvantri Jeevan Rekha's stock. It is important for investors to carefully consider these financials before making any investment decisions.